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ABSTRACT 
This study investigated the relationship between diabetic con-
trol and heart disease risk in diabetic subjects. Glycosylated hemo-
globin (Hb Alc) and high-density lipoprotein (HDL) levels were used 
as control and risk indicators. The purpose of the study was to 
describe the relationship between indicators of diabetic control and 
heart disease risk in diabetic subjects using conventional insulin 
injections and those same indicators when the subjects were receiv-
ing continuous subcutaneous insulin infusion from a portable battery-
powered pump. 
The study described changes in glycosylated hemoglobin (Hb 
Alc), high-density lipoprotein (HDL), cholesterol, and triglyceride 
levels during a control and experimental period each lasting six 
and three continuous months respectively. During the control pe-
riod, the subjects continued to use conventional insulin injections. 
Within the first and final week of the six month control period, 
Hb Alc, HDL, cholesterol and triglyceride levels were measured. 
During the first week of the three month experimental period the sub-
jects were instructed in the operation and management of the insulin 
infusion pump. The subjects used the infusion pump throughout the 
experimental period. Levels of Hb Alc, HDL, cholesterol, and triglyc-
eride were again measured during the final week of the experimental 
period. 
Descriptive analysis of relationships between Hb Alc, HDL, 
cholesterol, and triglyceride levels during the control and experi-
mental periods demonstrated that diabetic control improved signif-
icantly when the subjects used the insulin infusion pump. However, 
the relationship between diabetic control and heart disease risk in-
dicators -- HDL, cholesterol, and triglyceride -- was not conclu-
sive. It was concluded that other variables were interfering with 
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CHAPTER I 
REVIEW OF LITERATURE 
Introduction 
The prevalence of coronary atherosclerotic heart disease 
(CAHD) has Significantly increased in the last 60 years and is now 
the leading cause of death in the industrialized world (Hurst, 
Logue, Schlant & Wenger, 1978). The relationship between heart 
disease and diabetes has been studied repeatedly. In the Framing-
ham study, Steiner (1978) determined that morbidity for athero-
sclerotic heart disease (CAHD) in diabetics increases twofold in 
comparison to that in nondiabetics. Knowles (1978) reported that 
CAHD accounts for 71% of all deaths in diabetic patients whose 
diagnosis was made at age 20 or later. Current data indicates 
atherosclerosis proceeds more rapidly and extensively in diabetic 
persons than in nondiabetic persons; however, the process of athero-
sclerosis does not differ from nondiabetic persons (Colwell, Lopes-
Virella & Halushka, 1981). 
In order to explain the prevalence of CAHD in diabetic per-
sons, certain characteristics of diabetes have been related to the 
acceleration and extensiveness of atherosclerosis seen in diabetic 
persons. These characteristics -- hyperglycemia, hypoinsulinemia 
and abnormal platelet activity -- can be decreased towards normal 
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levels with good diabetic control which mimics normal metabolism. 
Evidence in the literature reveals that the continuous sub-
cutaneous insulin infusion pump provides better diabetic control 
than conventional insulin injections (Pickup, Keen, Parsons, 
Alberti, & Rowe, 1979). The continuous infusion of small amounts 
of insulin with a bolus infusion before meals is similar to normal 
pancreatic activity and produces near normal glucose concentration. 
There exist indicators for diabetic control and heart disease. 
The most accurate indicator for current diabetic control is the 
blood glucose measurement. Diabetics can measure their blood glu-
cose level at home with a reflectance meter by using capillary 
blood obtained from a finger prick. The indicator for long-term 
diabetic control is glycosylated hemoglobin (Hb Alc) measurement 
which is calculated in a laboratory. The most useful indicator of 
heart disease risk is high-density lipoprotein (HDL) levels. High-
density lipoprotein (HDL) levels correlate with the majority of 
commonly known heart disease risk factors. These indicators are 
useful to health care personnel in assessing diabetic control and 
heart disease risk. 
The purpose of this study was to describe the relationship 
between diabetic control and heart disease risk in diabetic persons. 
This study used glycosylated hemoglobin (HbAlc) and high density 
lipoproteins (HDL) levels as control and risk indicators, and de-
scribed relationships while the diabetics were using conventional 
insulin injections in comparison to results while receiving con-
tinuous subcutaneous insulin infusion by pump. 
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Heart Disease 
Coronary atherosclerosis is a pathologic condition which is 
characterized by abnormal lipid and fibrous tissue accumulation in 
the coronary artery wall. This disrupts the vessel function and 
reduces the blood flow to the myocardium. When blood flow to the 
myocardium is reduced significantly, myocardial ischemia results. 
This, in turn is responsible for angina, myocardial infarction, and 
sudden death (Hurst et a1., 1978). 
Pathogenesis of Atherosclerosis 
Three distinct layers make up the structure of the artery 
wall: the intima, media, and adventitia. The intima is bounded on 
the luminal side by a continuous single layer of endothelial cells. 
The outer boundary is a thin sheet of elastic fibers called the 
internal elastic lamina. Between these boundaries is an extra-
cellular connective tissue matrix. The media is made of diagonally 
oriented smooth-muscle cells surrounded by collagen, small elastic 
fibers, and proteog1ycans. The media and adventitia are separated 
by the external elastic lamina. The adventitia is composed of 
fibroblasts intermixed with smooth-muscle cells arranged between 
bundles of collagen and surrounded by proteoglycans (Ross & Glom-
set, 1976). 
Lipids are transported in the circulation. Proteins or poly-
peptides, known as apoproteins, perform the function of lipid 
carriers since lipids are insoluble in water. The lipids and apo-
proteins are known as lipoproteins. Four types of lipoproteins 
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have been identified: a) Chylomicrons; b) very-low-density lipo-
proteins (VLDL); c) low-density lipoproteins (LDL)j d) high-density 
lipoproteins (HDL). The LDL has the greatest atherogenic potential due 
to its ability to deposit lipids into arterial wall cells. TheHDLhas 
the least atherogenic effect (Hurst et al., 1978). 
Ross and Glomset (1976) have suggested a current common hy-
pothesis concerning the pathogenesis of atherosclerosis. The basis 
of their hypothesis lies in the similarity between atherosclerosis 
and arterial response to experimental injury. 
The atherosclerotic lesion starts with an injury to the endo-
thelium of the artery. For example, hypercholesterolemia or 
hypertension can injure the endothelium and cause desquamation. 
Injury to the endothelium causes an immediate platelet response. 
Platelets adhere to the subendothelial connective tissue at the 
site of injury. Once they adhere, the platelets aggregate and lose 
the contents of their granules into the artery wall. These platelet 
factors interact with plasma constitutents in the artery wall. One 
of these factors is mitogen, which stimulates focal proliferation 
of arterial smooth muscle cells. Smooth muscle-cells migrate from 
the media into the intima by going through the fenestrae, or open-
ings, of the internal elastic lamina. These cells then multiply, 
causing the intima to thicken rapidly. The proliferative cells 
are soon surrounded by newly formed collagen, elastic fibers, and 
proteoglycans. 
As the lesion progresses, lipids are deposited within the pro-
liferative cells and their surrounding connective tissue matrix. 
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Arterial extracellular matrix in culture forms glycosaminoglycan. 
Because glycosaminoglycan has an increased affinity to bind with 
low-density lipoproteins (LDL), it is believed that they may have 
an important role in the deposition of lipids during lesion forma-
tion (Ross & Glomset, 1976). 
During the smooth-muscle cell proliferation and lipid deposi-
tion, the endothelial cells attempt to regenerate and recover the 
exposed intima. Restoration of the endothelium ultimately occurs 
and the lesion regresses if the injury is limited. This leaves only 
a slightly thickened intimal layer which contains only a few new 
layers of smooth-muscle cells. 
However, if the injury to the endothelium is continuous or 
repeated, there is further proliferation of smooth-muscle cells, 
accumulation of connective tissue, and deposition of lipids. This 
will eventually form a fibrous cap or plaque. If the fibrous 
plaque becomes altered as a result of hemorrhage, calcification, 
cell necrosis, or mural thrornbosis, it becomes a complicated lesion. 
This complicated lesion is often associated with occlusive artery 
disease (Ross & Glomset, 1976; Colwell et al., 1981). 
In review, the sequence of events in atherosclerosis is: 
endothelial injury, platelet adhesion, platelet aggregation, plasma 
permeation of arterial wall, smooth-muscle cell migration and pro-
liferation, extra-cellular matrix (connective tissue) formation, 
and extra-cellular and intra-cellular lipid accumulation. 
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Heart Disease Risk 
Epidemiological studies have revealed certain risk factors 
which are associated with CAHD. These factors are age, sex, famil-
ial history, elevated serum lipid levels, diet, hypertension, smok-
ing, diabetes, obesity, sedentary living, and psychosocial tension. 
The presence of one risk factor does not give predictability of the 
occurrence or severity of CAHD. It has been recognized, however, 
that the presence, of two, three, or four risk factors has a pro-
gressive and synergistic effect of CAHD risk (Hurst et al., 1978). 
Recent studies in atherosclerosis research have focused on 
high-density lipoproteins (HDL) as a predictive risk factor (Hulley, 
Cohen & Widdowson, 1977; Miller, Thelle, F¢rde~& Mj¢s, 1977; 
Castelli, Doyle & Gordon, 1977; Van Gent, VanDerVoort & Hessel, 1978; 
Francis, 1980). A strong inverse correlation between plasma HDL and 
CAHD has been established. 
Miller and Miller (1975) postulated two mechanisms by which 
HDL may slow the atherogenic process: 
1. HDL may facilitate cholesterol transport from the arter-
ial wall cell. 
2. HDL may inhibit the uptake of cholesterol by inhibiting 
intake of LDL by arterial wall cells. Their study demonstrated a 
strong inverse relationship between plasma HDL concentration and 
the size of the body's cholesterol pool. This suggests that HDL 
limits the accumulation of cholesterol in arterial cells (Miller 
& Miller, 1975). 
Carew, Hayes, Koschinsky and Steinberg (1976) reported that 
HDL binds to the surface of porcine arterial smooth-muscle cells 
as effectively as LDL but is internalized and degraded much more 
slowly, thus inhibiting the uptake and degradation of LDL. They 
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also discovered that HDL suppresses the net amount of cell sterol 
content induced by LDL. Speculatively, a low HDL concentration leads 
to defective clearance of cholesterol and cell saturation, thereby 
accelerating the development of atherosclerosis. An increased HDL 
concentration seems to have a protective effect in that cholesterol 
clearance is more efficient. 
HDL and Established Risk Factors 
Age. In the Troms~ Heart Study report, Nj¢s, Thelle, F~rde 
& Vik-Mo (1977) reported changes in HDL levels with age. In females, 
0-49 years, the HDL cholesterol rose slightly, but not significant-
ly with age. The HDL levels did not change significantly in increas-
ing age in males either. Martin, Haskell and Wood (1977) in their 
study of distance runners in California reported that HDL choles-
terol increased with increasing age in active runners while controls 
showed a slight decrease or no change in HDL with increasing age. 
The development of atherosclerosis is dependent on time; thus 
a consistent relationship between age and CAHD depends on the ac-
companiment of other risk factors. 
Sex. Barr, Russ, and Eder (1951) observed that during the 
reproductive years women have decreased susceptibility to CAHD in 
relation to men. Women have substantially higher levels of HDL 
than men until age 50. From age 50 to age 80 there is a slight 
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decrease in HDL levels in women toward the male values (Gordon, 
Castelli, Hjortland, Kannel, & Dawber, 1977). These findings con-
tribute to an understanding of why men are more prone to develop 
atherosclerosis than women until the age of menopause; after age 
50, there is decreased sex difference in the incidence of athero-
sclerosis. 
Family History. The Framingham Study revealed that the child-
ren of coronary heart disease patients had lower HDL levels than 
children of healthy parents (Miller et al., 1977). The Troms¢ Heart 
Study discovered a positive correlation in pairs of family members 
involving the mother and sib-sib pairs of the same sex, suggesting 
that intrafamilial resemblance in HDL levels is sex-associated (Mj¢s 
et al., 1977). Other studies have confirmed that an individual 
with either parents or siblings affected by CAHD prior to age 50 
has a greater risk of developing the disease at a younger age (Hurst 
et al., 1978). Although familial tendency may be influenced by 
genetic transmission, other environmental factors inherent in family 
life should also be appraised. These factors included nutrition, 
socioeconomic level, and activity patterns. 
Elevated Lipid Levels. Hypercholesterolemia and hypertriglyc-
eridemia have been topics of interest for several years. The risk 
of atherosclerosis increases with high cholesterol levels. Most 
of the cholesterol in the body exists as LDL, and as LDL levels 
increase, HDL levels decrease. Therefore, a person with hyper-
cholesterolemia has a lower HDL level (Miller & Miller, 1975). 
There may also exist an increased risk of atherosclerosis with 
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hypertriglyceridemia. Plasma triglyceride exists predominantly as 
a component of VLDL. A negative correlation between VLDL and HDL 
has been reported (Miller & Miller, 1975). This is the same corre-
lation that exists between LDL and HOL. An explanation for this 
is that VLDL is a precursor of LDL (Colwell et al., 1981). These 
results coincide with previous results of strong correlations be-
tween hypercholesterolemia, hypertriglyceridemia, and CAHD. 
Diet. A diet rich in calories, saturated fat, and cholesterol 
is associated with increased CAHD risk. Hulley et al. (1977) re-
port tha t there wa s an inc rea se in HDL 1 evel sin those pa rt i c i pants 
who adhered IIwell" to a diet designed to lower total serum choles-
terol concentration. For those whose adherence was judged "fair" 
or "poor ," there was little change in HDL levels. 
Hypertension. There is a significant association between 
hypertension and CAHD. However, epidemiologic studies suggest that 
hypertension accelerates atherosclerosis only when hyperlipidemia 
is present. When hyperlipidemia is present, the effect of hyper-
tension is related to the extent of lipid abnormality (Hurst et 
al., 1978). The Troms¢ Heart Study concluded there was no signi-:-
ficant difference in HDL levels between case and control groups 
with hypertension (Miller et al., 1977). The relationship between 
HDL and lipid abnorn~lities has been discussed previously. 
Smoking. The effect of smoking, as a risk factor, is propor-
tional to the number of cigarettes smoked per day. The risk of 
developing CAHD increases two to six times for smokers as compared 
to nonsmokers (Hurst et al., 1978). Pozner and Billimoria (1979) 
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observed that LDL and VLDL levels were significantly increased with 
heavy smoking. A decrease in HDL levels was also observed, although 
it was not significant. 
Diabetes. Diabetics tend to develop a greater number of athero-
sclerotic lesions, more extensive lesions, and more significant 
lesions at an earlier age. Calvert et al. (1978) found low HDL 
levels in diabetics who had a high hemoglobin Alc (HbAlc) level, 
which is a measurement of diabetic control. 
Obesity. The degree of obesity determines the amount of 
atherosclerotic risk. Obese people frequently develop hypertension, 
diabetes, and hyperlipidemia, thus increasing their risk for CAHD. 
There is a strong inverse correlation between weight and HDL levels 
(Gordon et al., 1977). 
Sedentary Living. Sedentary living enhances the probability 
of CAHD. In contrast, increased activity can actually decrease 
other risk factors, such as obesity, hypertension, hyperlipidemia, 
and psychosocial tension. Also, very active persons are found to 
have increased HDL levels (Lehtonen & Viikari, 1978). Therefore, 
people with a sedentary lifestyle would be expected to have low 
HDL levels. 
Psychosocial Tension. Psychosocial tension or personality 
type and CAHD have consistently been associated in epidemiological 
studies of industrialized countries. Anxiety has been shown to 
increase serum cholesterol and increase the tendency for hyper-
tension. Nevertheless, exact relationships of stress and CAHD 
have been difficult to prove since there are no satisfactory 
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available methods to measure degrees of stress. No present research 
study has attempted to relate HDL levels with stress, although the 
increase in serum cholesterol would be similar to hypercholestero-
lemia previously mentioned (Francis, 1980). 
In summary, HDL levels have an inverse relationship with eight 
of the established eleven risk factors. Levels of HDL do not change 
significantly with age or hypertension. Studies of the relationship 
between HDL and psychosocial tension have not been reported. The 
Troms¢ Heart Study reported that low HDL levels are a common ante-
cedent of clinical CAHD and do not merely follow its onset as a 
consequence. In the eight variables studied, HDL levels made the 
most important independent contribution to the prediction of future 
CAHD in young men, with coronary risk increasing with decreasing 
HDL levels. An individual could be predicted as likely or unlikely 
to develop CAHD with 85% accuracy during the two-year follow-up 
(Miller et al., 1977). This demonstrates the importance of measur-
ing HDL levels in calculating CAHD risk. 
Diabetes and Heart Disease 
Before the discovery of "insul"in, people with diabetes mellitus 
died from infections and diabetic coma; now they die of cardio-
vascular diseases (Zdanov & Vihert, 1976). The relationship between 
diabetes and heart disease has been established. It is believed 
that the inherent characteristics of the diabetic state accelerate 
the atherosclerotic process. 
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Diabetic Characteristics 
Insulin and Glycemia. Insulin-dependent diabetics use exoge-
nous insulin to maintain normoglycemia. This insulin is adminis-
tered by single or multiple injections of one or more insulin prep-
arati·ons. Insulin preparations have onset times ranging from 
one half to eight hours, peak action times (when greatest amounts 
are in the circulation) spanning between two and twenty-four hours, 
and duration of action times ranging between eight to thirty-six 
hours. Each insulin administration results in insulin-level fluc-
tuations of hypoinsulinemia, normoinsulinemia and hyperinsulinemia 
which are related to the given insulins onset, peak action, and 
duration of action times. Hypoinsulinemia also occurs when the 
diabetic's insulin requirement increases, such as during illness, 
infection, trauma or surgery. Hyperinsulinemia develops when there 
is a delay or omission of a meal, increased exercise, or an error 
in measurement resulting in excess dosage (Beland & Passos, 1981; 
Luckman & Sorensen, 1980). 
Both hyperinsulinemia and hypoinsulinemia can cause hypertri-
glyceridemia. Hyperinsulinemia, or an excessive amount of insulin 
bathing the liver, is directly related to an increased rate of VLDL 
triglyceride production. Hypoinsulinemia increases the mobilization 
of stored triglyceride from adipose tissue in addition to decreas-
ing the uptake of triglyceride by adipose tissue. Hypoinsulinemia 
also inhibits lipoprotein lipase activity which regulates the re-
moval of circulating triglycerides (Steiner, 1978). The majority 
of triglycerides are transported by VLDL in the circulation. Very 
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low-density-lipoproteins provides a substrate for hepatic production 
of LDL which is the major contributor to cholesterol accumulation in 
the intima (Colwell et al., 1981). As a result, both hyperinsu-
linemia and hypoinsulinemia indirectly cause increased LDL. As LDL 
levels increase, HDL levels decrease (Miller & Miller, 1975). 
Hypoinsulinemia results in hyperglycemia. During hyperglyc-
emia the uptake of glucose is not limited in the lens of the eye, 
Schwann cells in nervous tissue, and in the artery wall. Within 
these cells, glucose is converted to sorbitol by the enzyme aldose 
reductase and follows the "polyol pathway.1I Sorbitol is not freely 
diffusible across the cell membrane, and so it remains in the cell 
where it is metabolized slowly_ The accumulation of sorbitol intra-
cellularly precipitates osmosis and consequent swelling of the cell. 
This produces electrolyte alterations, loss of sodium pump activity, 
and altered cellular metabolism (Skyler, 1978). 
Abnormalities in Platelet Activity. Abnormalities in platelet 
activity have also been noted in diabetes. Platelet adhesiveness 
and aggregation are increased. Colwell et ala (1978, 1981) reported 
a relationship between the increased platelet adhesiveness in dia-
betics and the decreased platelet adhesiveness in patients with 
von Willebrand's Disease. For patients with von Willebrand's Dis-
ease, normal platelet adhesiveness can be restored by the addition 
of factor VIIIR: WF, a glycoprotein which is found in large quan-
tities in cryoprecipitate. The relationship was further demon-
strated in pigs that were markedly deficient in factor VIIIR: WF; 
atherosclerosis could not be induced to advanced stages even with 
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forced fat feeding. Therefore, they concluded that elevated factor 
VIIIR: WF levels in diabetes contribute to increased platelet ad-
hesiveness. 
Hypersensitivity to aggregating agents, such as ADP, epi-
nephrine or collagen, can be shown in platelet-rich plasma of dia-
betics. Platelet release of granules or aggregation at low concen-
trations of these agents can be suppressed in diabetics by prosta-
glandin synthetase inhibitors. If the prostaglandin synthetase 
is not inhibited, platelets become hypersensitive to aggregating 
agents. Thus, increased prostaglandin synthetase activity appears 
to be present in platelets from diabetics (Colwell, 1978). 
Diabetic Factors and Atherosclerosis 
The inherent characteristics of diabetes have been identified 
as hypoinsulinemia, hyperinsulinemia, hyperglycemia, and increased 
platelet adhesiveness and aggregation. Each of these will be re-
lated to the pathogenesis of atherosclerosis as described in the 
previous section. For review, the sequence in events of athero-
sclerosis is: endothelial injury, platelet adhesion and aggre-
gation, smooth-muscle cell migration and proliferation, extra-
cellular matrix formation, and lipid accumulation. 
Endothel ial Injury. Hyperglycemia can cause endothel ial 
injury (Colwell, 1978). The endothelial cells of the artery do not 
limit glucose transport into the cell. These cells contain aldose 
reductase, which causes the glucose to enter the polyol pathway. 
This pathway, the accumulation of sorbitol and water, causes the 
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cell to swell, thus altering normal function. Endothelial injury 
follows any significant swelling. Therefore, the prevalence of 
coronary atherosclerosis is higher in the presence of hyperglycemia. 
This association is independent of serum cholesterol and blood pres-
sure levels (Epstein, 1967). 
Platelet Adhesion. Platelet adhesion occurs in response to 
endothelial injury. In a diabetic person whose platelet adhesive-
ness is increased, greater numbers of platelets adhere to the site 
of injury and come in contact with aggregating agents. 
Platelet Aggregation. Platelet aggregation is increased due 
to the hypersensitivity of platelets to aggregating agents. The 
increased adhesiveness and aggregation act in concert to enhance 
and facilitate the following events in atheroscl.erosis. 
Smooth-Muscle Cell Migration and Proliferation. Smooth-muscle 
cell migration and proliferation are stimulated by platelet factors 
as a result of platelet aggregation. The migration and prolifera-
tion are further accelerated by the presence of insulin (Colwell 
et al., 1981). During periods of hyperinsulinemia, this produces 
larger amounts of connective tissue matrix formation and intimal 
thickening. 
Lipid Accumulation. Extracellular and intracellular lipid 
accumulation is dependent upon the amount of lipids in the blood 
and the binding capacity of the proliferative cells. Insulin in-
creases the lipoprotein uptake in the arterial smooth-muscle cells 
and directly affects the arterial wall lipid metabolism leading to 
lipid accumulation (Bierman & Brunzell, 1978). Hyperlipidemia is 
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the result of hyperinsulinemia and hypoinsulinemia; thus lipid 
accumulation is more extensive and greater as fluctuations in insu-
lin concentration occur. 
The effect of di abet i c factors ; n each event of the a therosc 1 er-
otic process has been identified, accounting for the fact that athero-
sc;lerosis proceeds more rapidly and extensively in diabetic persons. 
Diabetic Control 
Diabetic control is characterized by normoglycemia. The 
failure to maintain normoglycemia in diabetics is largely due to 
the inability of subcutaneously administered exogenous insulin to 
mimic the pattern of insulinemia in nondiabetics. When normoglyce-
mia and normal insulinemia cannot be maintained, the diabetic fac-
tors of hypoinsulinemia, hyperinsulinemia and hyperglycemia ensue 
(Service & Nelson, 1980). The effect of diabetic control on plate-
let function is unclear. However, some studies have demonstrated 
that when severe hyperglycemia is corrected with insulin therapy, 
the enhanced platelet aggregation response is decreased (Peterson, 
Forhan & Jones, 1980; Colwell et al., 1981). Since diabetic con-
trol can decrease these diabetic factors, and these factors are 
directly related to atherosclerosis, then diabetic control could 
decrease and possibly prevent atherosclerosis in diabetic persons. 
Diabetic Control Tests 
Management of diabetic control requires measurement of 
glucose to guide insulin therapy. Glucose measurements can be made 
from urine and from blood specimens. 
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Urinalysis. The advantages of testing urine for glucose are 
low cost, lack of body invasion, and avoidance of pain. The major 
disadvantage is that urine test results may be misleading. Urine 
glucose is often high with concurrent normoglycemia. This is 
commonly due to incomplete voiding of glucose-positive urine in 
the bladder before the second voided specimen. Urine glucose mea-
surement will not indicate hyperglycemia if the diabetic person has 
high renal threshold of glucose clearance, diminished glomerular 
filtration rate, or increased tubular reabsorption of filtered 
glucose. These factors cause errors in estimating blood-glucose 
levels from urinalysis,making diabetic control assessment more 
difficult (Danowski, Ohlse, Fisher, & Sunder, 1980). 
Blood Glucose. Blood glucose measurements are accurate but 
only reflect diabetic control at the time the blood sample is ob-
tained. Blood glucose may be measured in the physician's office or 
hospital laboratory, or at home by the diabetic person. Home 
analysis of blood glucose may be done with a glucose-oxidase rea-
gent strip and reflectance meter which requires a "finger stick" 
blood sample. In the majority of diabetics who monitor blood glu-
cose levels as a guide to multiple injections of insulin, diabetic 
control is improved (Danowski et al., 1980). 
Peterson et al. (1980) reported that their diabetic patients 
had greater compliance and better diabetic control when they moni-
tored their blood glucose with reflectance meters before and after 
meals. Glucose measurement by reflectance meter correlated with 
laboratory measurement of glucose with a correlation coefficient 
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between 0.92 and 0.97. The same correlation existed with all three 
meters currently available on the market. 
Glycosylated Hemoglobin. Glycosylated hemoglobin serves as 
an integrator of the mean blood glucose over several preceding weeks 
(Peterson et al., 1980). Hemoglobin undergoes nonenzymatic gly-
cosylation in the presence of plasma glucose. Normally 5% of total 
hemoglobin is glycosylated. The covalent linkage of glucose to 
hemoglobin results inthe formation of chromatographically distinct 
additional components to the hemoglobin itself. The most prevalent 
minor component was designated by Allen (1958) as Hb Alc according 
to Bunn. Interest in Hb Alc was intensified by the discovery in 
1968 that there is a two- to three-fold increase in Hb Alc in pa-
tients with diabetes (Bunn, Gabbay, & Gallop, 1978). 
The HbAlc is formed slowly and continuously during the 120 day 
life span of the erythrocyte (Bunn et al., 1978). The cumulative 
amount of Hb Alc is proportional to the average glucose concen-
tration to which the erythrocyte is exposed. Gonen, Rubinstein, 
Rochman, Tanega & Horwitz (1977) discovered a significant posi-
tive correlation between Hb Alc and fasting glucose level, mean 
glucose level (several samples per day), and the highest glucose 
level in a day. A partial correlation coefficient showed that the 
Hb Alc level was mainly dependent on glucose response rather than 
the fasting glucose level. 
Davis, Nicol, McCann and Calder (1978) recorded that in poorly 
controlled diabetes, diabetics have a mean Hb Alc level 50% higher 
than normal. After diabetic control was improved, Stanton and 
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Davis (1978) observed that Hb Alc levels did not decrease until 
three to four weeks later. He concluded that Hb Alc reaches a 
stable level of equilibrium after two to three months of improved 
control. Ditzel and Kjaergaard (1978) reported that Hb Alc levels 
returned to normal in twenty-five to eighty days, depending on 
initial Hb Alc level and blood glucose control. These data demon-
strate how Hb Alc is useful in assessing diabetic control of pre-
vious months. 
Relationships between Hb Alc and age, sex, duration of diabe-
tes, and mode of treatment have been analyzed. Davis et al. (1978) 
obtained a significant correlation (Q< 0.01) of Hb Alc and dura-
tion of diabetes when the diabetes was in poor control. When the 
diabetes was well controlled with insulin, there was no correlation 
with age or duration of diabetes. However, Tze, Thompson and 
Leichter (1978) concluded there is no correlation between Hb Alc 
and age, sex, or duration of diabetes. 
Graf, Halter and Porte (1978) have postulated a theoretical 
maximum of glycosylated hemoglobin of 23.1% of total hemoglobin. 
Previous studies of diabetics have shown Hb Alc levels approach but 
do not exceed this value. Further evidence of maximum saturation 
level is found when, in very poorly controlled, frequently hyper-
glycemic diabetics, the Hb Alc levels are not elevated as high as 
expected. There is much evidence that Hb Alc is sensitive to mod-
erate hyperglycemia, which in actuality is the current major prob-
lem in assessing diabetic control (Stanton & Davis, 1978). There-
fore, Hb Alc is useful in assessing previous diabetic control; 
however, differentiation of degrees of poor diabetic control is 
decreased as Hb Alc levels approach maximum values. 
The urine or blood glucose test may be used by the diabetic 
or health-care provider to assess diabetic control. However, the 
blood glucose measurement is more accurate in determining normo-
glycemia. Blood glucose measurement with a reflectance meter is 
most useful for immediate diabetic control assessment. In con-
trast, Hb Alc is most useful in determining quantitative diabetic 
control over preceding weeks and months. 
Diabetic Control Methods 
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There are four major differences between normal endogenous 
insulin secretion and exogenous insulin therapy. During endogenous 
insulin secretion, the insulin is released in a pulsatile manner 
in response to glucose stimulation. Thus, blood glucose and insu-
lin levels rise and fall simultaneously. In contrast, exogenous 
insulin absorption is not a response to glucose stimulation but is 
reliant on solubility properties of the insulin and absorption 
rate from injection site. No homeostatic control mechanism is 
present in diabetic persons. Therefore, diabetic control methods 
should provide a balance of energy expenditure (exercise), energy 
availability (diet), and insulin needed for effective utilization 
of energy (Skyler, 1978). 
Goals for the control method chosen are to: a) achieve normo-
glycemia; b) provide insulin in concert with meals; c) allow maxi-
mum flexibility in diet, activity, and insulin administration; 
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d) have maximum patient understanding and involvement in therapy. 
In order to obtain these goals, the optimal insulin therapy should 
provide peaks of insulin action at different times throughout the 
day. This can be produced by multiple doses of regular insulin 
before meals and bedtime or a split-mixed insulin regimen. This 
regimen splits the insulin dose between the before-breakfast and 
before-supper injections and mixes a short-acting and an inter-
mediate-acting insulin for each dose. The rationale for these 
regimens is that they more closely mimic endogenous insulin secre-
tion. Also, there is more flexibility in altering activity, diet, 
and insulin injection time. These regimens are superior to one or 
two insulin preparations injected before breakfast because they are 
less likely to precipitate hypoglycemia, hyperglycemia, hyperinsu-
linemia, or hypoinsulinemia at any time during the day or night 
(Skyler, 1978). 
In the quest to achieve better diabetic control, calculated 
repeated doses of insulin have gained more popularity. This has 
led to the experimental use of continuous insulin infusion pumps. 
Pickup et al. (1979) observed seven insulin-dependent diabetics 
during 24 hours of continuous insulin infusion. Blood glucose 
levels and the major intermediary metabolites -- lactate, pyruvate, 
3-hydroxybutyrate, alanine -- were compared to pre-pump levels and to 
levels in 17 nondiabetics. The mean blood-glucose level was not 
significantly different from that of nondiabetics. Blood concen-
trations of the intermediary metabolites approached those of non-
diabetics, demonstrating the control that can be obtained with the 
infusion pump. 
Following this study, Pickup et ala (1979) investigated out-
patient use of the infusion pump. Pump use was instigated in the 
hospital for six patients. These patients used the pump for 48 
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to 111 days. During this time, they monitored their diabet~c con-
trol by using glucose-oxidase reagent strips with reflectance meters 
and managing pump operation and dosage control. The subcutaneous 
infusion route was used to avoid the thrombosis and infection pos-
sible with intravenous route. Cannulas were reimplanted every 
two to eight weeks or as necessary. During bath times, the pump 
was disconnected and the tubing covered with a cap. The results of 
this investigation were: a) statistically significant decreases 
in mean blood glucose for five of six subjects; b) Hb Ale decreased 
to normal range; c) insulin dosage decreased for five of six sub-
jects; d) no visible or palpable inflammatory reaction or lipo-
dystrophy; e) no micro-organisms in culture of cannula tips. 
Tamborlane, Sherwin, Genel and Feliz (1979) examined lipid 
levels of eight patients using infusion pumps for seven to fourteen 
days. Plasma cholesterol, triglycerides, and free fatty acids were 
elevated above normal during conventional insulin therapy and de-
creased to normal after seven days of infusion pump use. These 
impressive metabolic corrections with continuous insulin infusion 
pumps use give a promising future to diabetic persons. 
Keen, Pickup, Viberti, Bilous and Williams (1981) have de-
scribed requirements for a successful infusion pump (1 to 8) and 
infusion pump therapy (9 to 10): 
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1. Reliable pump 
2. Capable of basal and bolus rates 
3. Small, light, robust 
4. Removable 
5. Controlled by diabetic 
6. Simple software 
7. Self-monitoring system 
8. Nocturnal security system 
9. Education and motivation of diabetic 
10. Physician discretion. 
While investigating the use of the infusion pump, Keen et al. 
(1981) reported that blood-glucose profiles for IIbrittle" diabetics 
were no better with pump use than that with multiple injections. 
He also studied metabolic response to abrupt discontinuance of in-
sulin infusion by pump failure or by obstruction. When discontinu-
ance occurred during waking hours, the patient perceived the change 
by diabetic control test results and followed recommended action. 
When it occurred at night, glycemia did not change for one hour, 
rose at a diminishing rate for the next four hours, then leveled 
off spontaneously. The plateau was about 4.5 mmol/L above base-
line level. At the end of nine hours sleep, the subjects felt 
mildly unwell; however, they all recovered after resuming insulin 
infusion. The use of the infusion pump is becoming more common and 
possibilities for long-term use are increasing. 
In summary, the relationship between diabetes and heart dis-
ease has been reviewed. Diabetic characteristics amplify the events 
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of the atherosclerotic process, although this amplification can be 
decreased with good diabetic control. Better diabetic control can 
be provided by the continuous subcutaneous insulin infusion pump 
than by conventional insulin injections. Assessment of long-term 
diabetic control and heart disease risk can be indicated by Hb Alc 
and HDL levels, while current diabetic control can be assessed by 
blood glucose levels. 
There is a need for health-care personnel to understand the 
relationship of diabetes and heart disease. Nurses come in contact 
with large numbers of diabetic and CAHD patients, and thereby use 
their knowledge about diabetes and heart disease in clinical care 
and education of diabetics. In the clinical setting they relate 
the disease process of the client to diabetic control methods, dia-
betic control tests, and assessment of diabetic control and heart 
disease risk. In planning patient education, they require knowledge 
of methods to improve diabetic control and decrease heart disease 
risk. Therefore, an understanding of diabetes and CAHD will allow 
for comprehensive nursing care for diabetic and heart disease pa-
tients. 
conceptual framework 
Diabetes is a metabolic disorder resulting from insufficient 
insulin. Although much is known about this disease, a cure or pre-
vention is not currently possible. Since the development of exoge-
nous insulin, diabetic persons no longer die from ketoacidosis; 
instead they die from macrovascular and microvascular complications. 
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A major macrovascular complication of diabetes is heart dis-
ease (See Figure 1). Coronary atherosclerotic heart disease (CAHD) 
results from coronary atherosclerosis which decreases the blood cir-
culation to the heart. Epidemiological studies have determined that 
no single factor is responsible for atherosclerosis, but multiple 
factors contribute to the process. These factors, recognized as 
risk factors, are used to determine heart disease risk. The cor-
rection or removal of the risk factors prevents or decreases the 
heart disease risk (Hurst et al., 1978) (See Section A, in 
Figure 1). 
Hurst et al. (1978) have classified the risk factors as major, 
minor, modifiable, and nonmodifiable (See Table 1). A major risk 
factor is one having a high correlation with heart disease. Clas-
sification as a modifiable risk factor suggests a specific change 
in the diabetic state may decrease heart disease risk. Diabetes 
is a major modifiable risk factor (See Section B, in Figure 1). 
Diabetes cannot be cured, but it can be controlled (See Sec-
tion C, Figure 1). In diabetes, there is a progressive loss of 
glucose homeostasis which is directly proportional to the amount 
of insulin present. Glycemia is produced by the ingestion of 
food, and glucose homeostasis is obtained by the presence of insu-
lin. Thus with insufficient insulin, as seen with diabetes, glu-
cose homeostasis cannot be achieved. Glucose homeostasis can 
be restored with exogenous insulin in calculated amounts which 
mimic the pattern of isulinemia and glycemia in healthy persons 
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Figure 1. Conceptual framework 
Table 1 
Risk Factors for Coronary Atherosclerotic Heart Disease 
(CAHD) 
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Elevated lipid levels 









Note. Adapted from Hurst et al., 1978. 
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indication of a good diabetic control. 
Several tests are available to monitor diabetic control (See 
Section D, Figure 1). These tests are the urinalysis, blood glu-
cose, and glycosylated hemoglobin. The urinalysis gives an indi-
cation of blood glucose. However, it is only accurate and reliable 
when the renal threshold is known, as a significant relationship 
exists between renal threshold and glycosuria. Blood-glucose levels 
give an accurate assessment of diabetic control at one point in 
time but do not reflect previous variations. Glycosylated hemo-
globin gives a quantitative assessment of diabetic control during 
the preceding weeks (Tattersall, Walford, Peacock, Gale & Allison, 
1980) (See Section E, Figure 1). Urine glucose levels, blood glu-
cose levels, and glycosylated hemoglobin levels increase above 
normal with poor diabetic control and decrease to normal range with 
good diabetic control. Thus, each is useful in assessing diabetic 
control. 
Different methods are employed by diabetic persons to obtain 
normoglycemia or diabetic control (See Section F, Figure 1). These 
methods are diet, oral agents, and insulin preparations. The method 
which achieves the best diabetic control should be the one used 
by each diabetic person. Insulin-dependent diabetics inject one 
or a combination of insulin preparations once, twice, or more a 
day. Insulin is administered subcutaneously into the adipose tis-
sue of the upper arms, thighs, buttocks, or abdomen. An innovation 
in insulin administration is the continuous subcutaneous insulin 
infusion pump (See Section G, Figure 1). Continuous infusion of 
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insulin with bolus amounts infused before meals duplicates insulin-
emia patterns of nondiabetic persons more closely than conventional 
insulin injections. 
If the diabetic control method does not mimic the nondiabetic 
state, certain characteristics which are innate to diabetes develop 
(See Section H, Figure l). These characteristics are hypoinsulin-
emia, hyperinsulinemia, hyperglycemia, and abnormal platelet acti-
vity (Colwell et al., 1981). With good diabetic control, these 
characteristics decrease and normal metabolism is present. If dia-
betic control is poor, these characteristics increase in abnormal-
ity. 
Colwell et al. (1981) have reported that these diabetic 
characteristics -- hypoinsulinemia, hyperinsulinemia, hyperglycemia, 
and abnormal platelet activity -- may induce or accelerate the 
atherosclerosis of heart disease. Hence, if these diabetic char-
acteristics can be decreased with good control, as previously indi-
cated, then the heart disease risk should also decline (See Section 
I, Figure l). 
Since no single factor is known to be useful in calculating 
heart disease risk, high density lipoprotein (HDL) levels have been 
used (See Section J, Figure l). High density lipoproteins (HDL) 
have a protective effect against cholesterol accumulation, the 
major component of atherosclerosis (Colwell et al., 1981). The 
level of these lipoproteins decreases when other heart disease 
risk factors are present and increases in their absence. This in-
dicates that high-density lipoproteins (HDL) can be used as a 
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reliable heart disease risk indicator (Francis, 1980). 
In order to examine the relationship of diabetic control and 
heart disease risk, high-density lipoprotein levels can be cor-
related with glycosy1ated-hemog1obin levels (See Section K, Figure 
1). Glycosylated hemoglobin provides a quantitative assessment 
of heart disease risk over several preceding weeks. This is an in-
verse relationship -- as glycosy1ated-hemoglobin levels decrease, 
high-density lipoprotein levels increase (Calvert, Mannik, Graham, 
Wise & Yeates, 1978). 
This investigation used the continuous subcutaneous insulin 
infusion pump to improve diabetic control after a period of time 
(control period) in which the diabetic person used conventional 
insulin injections (See Section L, Figure 1). Glycosylated hemo-
globin and high-density lipoprotein levels were recorded during the 
control period, just before instituting the infusion pump and after 
the infusion pump had been used for three months. These data were 
used to determine the effect of diabetic control on heart disease 
risk. 
Purpose and Problem 
The general purpose of this study was to describe the rela-
tionship between indicators of diabetic control and heart disease 
risk in diabetic subjects using conventional insulin injections and 
those same indicators when the diabetics were receiving continuous 
subcutaneous insulin infusion from a portable battery powered pump. 
Research Questions 
The research questions were: 
1. Will Hb Alc and HDL levels change during a six month 
control period of conventional insulin management of diabetes? 
2. Will Hb Alc and HDL levels be inversely related during a 
six month control period? 
3. Will Hb Alc levels decrease from control period levels 
after the insulin pump has been used for three months? 
4. Will HDL levels increase from control period levels after 
the insulin pump has been used for three months? 
5. Will Hb Alc and HDL levels be inversely related after 
three months of insulin pump use? 
6. Will an inverse relationship exist between HDL and cho-
lesterol levels? 




Diabetic Person: A diabetic person was a person who required 
exogenous insulin to maintain normoglycemia. Additionally, a dia-
betic person involved in this investigation had neuropathy and 
possibly nephropathy or retinopathy. An internist, opthamologist, 
and neurologist respectively documented these microvascular 
complications by medical history, physical examinations and labora-
tory tests. 
Diabetic Control: Diabetic control was control of glucose 
32 
homeostasis which was achieved by the adequate administration of 
exogenous insulin. The measurement of long-term diabetic control 
was the blood Hb Alc level, and the measurement of current diabetic 
control was blood-glucose levels as measured by standard laboratory 
procedure. 
Heart Disease Risk: Heart disease risk was the considered poten-
tial or risk a person had for the development of CAHD. The index 
of heart disease risk was the blood HDL levels as measured by stan-
dard laboratory procedure. 
Control Period: The control period was a period of six con-
tinuous months in which the diabetic person continued to use con-
ventional insulin injections to effect diabetic control. 
Experimental Period: The experimental period was a period 
of three consecutive months in which the diabetic person used the 





This investigation used a descriptive research approach, with 
all subjects who met the study criteria acting as their own controls. 
After a control period using conventional insulin injections, insu-
lin infusion pump treatment was instituted and used for the experi-
mental period. This study described changes in Hb Alc and HDL levels 
during the control and experimental periods. 
Sample 
This study used a convenience sample of five diabetic subjects 
who were participating in a study conducted by four physicians. 
The criteria for these subjects was the presence of measurable pe-
ripheral neuropathy, and a willingness to complete study requirements. 
Other complications of diabetes may have been present. Any subjects 
excluded were those excluded from the larger study. Data obtained 
from these subjects was used to answer the research questions. 
Procedure 
This investigation took place simultaneously with a larger 
study by four physicians. The subjects continued with biweekly or 
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more frequent appointments with the physicians for assessment of 
diabetic control, laboratory procedures, and physican examination 
as scheduled. All laboratory tests were done at a hospital except 
the capillary blood glucose determinations which were done by the 
subjects at home. 
Basal flow rate and bolus amounts of insulin, blood glucose 
levels before meals and at bedtime, and other events related to 
diabetic control were recorded by the subjects on data sheets 
designed for the larger study. The physician and subject reviewed 
the data sheet during each clinic appointment to assess diabetic 
control during the preceding two weeks. 
This investigation involved a control and experimental period 
lasting six and three continuous months respectively. During the 
control period, the subjects continued using conventional insulin 
injections. Within the first and final week of the control period, 
Hb Alc and HDL levels were measured. In the first week of the ex-
perimental period, the subjects were instructed as outpatients in 
the operation and management of the continuous subcutaneous insulin 
infusion pump. 
Determination of the insulin infusion pump basal flow and bolus 
rates were calculated from the insulin dose used in the control 
period. These calculated flow rates required further adjustment 
after diabetic control was assessed while the subject was using the 
infusion pump. Repeated changes in insulin flow rates were usually 
necessary before desired diabetic control was achieved. 
The subjects used the infusion pump throughout the experimental 
period. During the final week of the experimental period, Hb Alc 
and HDL levels were again measured. Relationships of Hb Alc and 
HDL levels were compared and described. 
Instruments 
Routine equipment which included tourniquet, needle, needle 
holder, and vacu-tainer, were used to collect blood samples for 
Hb Alc and HDL levels. 
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The hospital laboratory received the blood samples and quanti-
fied Hb Alc and HDL levels. The Hb Alc levels were determined by 
using the Fast Hemoglobin TM Test System (distributed by Isolab 
Incorporated). The HDL levels were determined by a Micro-Centrifi-
cal-Analyzer Multi-Stat III (manufactured by Instrumentation Lab). 
The insulin infusion pump was an Auto-Syringe Model AS-6C. 
The overall size of the pump was 3.3 x 6.3 x 1.0 inches; the 
weight, 9.6 ounces. The pump could be programmed for basal flow 
rate and bolus amounts with an accuracy of flow rate of ± 1%. 
A 3cc. syringe was used to store the prescribed amount of 
regular insulin which had been diluted with normal saline to make 
a total volume of 2.8 cc. The dilution was determined individually 
for each subject in order to last a minimum of 24 hours. 
A digital display showed "distance units" of insulin to be 
infused in 24 hours. Each distance unit equaled 0.028 cc. of di-
luted insulin. Since 100 distance units were in 2.8 cc. and the 
number of diluted insulin units were known, the number of insulin 
units in each distance unit could be calculated. 
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Alarms were programmed to sound when the battery was low, 
insulin infusion was too rapid (runaway), high pressure or an ob-
struction was present. Two rechargeable batteries were used, each 
of which lasted for 24 hours. The insulin pump was encased with 
a high impact plastic case which also covered the syringe. 
Micro-Volume Extension Sets were connected to the syringe 
in the pump by a Luer-Lock Adapter. The 42 inch tubing was soft, 
pliable and kink resistant. A 27-gauge needle was connected to 
the tubing. The needle was inserted into the abdomen, and the tub-
ing was secured to the skin using adhesive or plastic tape. 
The infusion pump was carried on a belt inconspicuously at the 
subject's side. Both the infusion pump and tubing were contained in 
a carry-ing case which had a loop for the insertion of a belt. Hhi1e 
the case was attached to the belt, one side could be detached for 
operating the pump and viewing the digital display. When the subjects 
were sleeping, the pump was placed under the pillow or on a bedside 
stand. 
Subjects monitored their diabetic control at home by measuring 
blood-glucose using glucose oxidase reagent sticks (Dextrostix, 
Ames Company) before each meal and at bedtime. The results of each 
blood-glucose determination were recorded on data sheets by the 
subjects. 
Human Subjects Considerations 
Diabetic subjects signed an informed consent for this investi-
gation. Since this investigation took place simultaneously with 
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the study by four physicians, extra blood samples were not needed 
for Hb Alc and HDL level determination. The subjects were under 
physician supervision throughout the investigation. All services 
and procedures related to the study were done without expense to 
the subjects. Also, subject identification was not revealed in re-
porting investigation results. 
CHAPTER III 
RESULTS 
Group Biographical Data 
Five subjects completed the study requirements, four female 
and one male. The age ranged from 26 years to 31 years with a mean 
age of 27.8 years. 
Four of the five subjects (80%) had a family history of dia-
betes mellitus. Table 2 describes the incidence of diabetes for 
family members. Family history was separated into groups of sib-
lings, parents, maternal ancestry line, and paternal ancestry line. 
Ancestry lines include aunts, uncles, cousins, and grandparents. 
Table 3 presents the subjects' age of diabetic onset, years 
duration of diabetes, and years of insulin use. The age of on-
set ranged from 10 to 25 years with a mean of 14.6 years. The 
duration of diabetes ranged from 5 to 15 years with a mean of 12.4 
years. The years of insulin use also ranged from 5 to 15 years 
with a mean of 12.4 years. 
Prestudy insulin dose, type of insulin, and injection sched-
ule are provided in Table 4. Total insulin dose ranged from 30 
to 50 units. Four subjects used mixed insulins. Three subjects 

























Subject Age of Onset Yea rs Dura t ion Years of Insulin 
Use 
10 15 15 
2 10 15 15 
3 16 13 13 
4 25 5 5 
5 12 14 14 
Mean Value 14.6 12.4 12.4 
Table 4 
Prestudy Insulin Dose and Schedule 
A.M. 
Subject Sa LC 
15 15 
2 10 12 
3 5 
4 20 10 
5 30 
as = Short-acting insulin 
bI = Intermediate-acting insulin 














insulin three times a day. 
All subjects had one or more diabetic complication as documen-
ted by medical history, physical exam, and diagnostic tests. These 
complications included neuropathy, retinopathy, and renal disease. 
Table 5 shows the distribution of diabetic complications. Most prev-
alent complications included neuropathy (100%) and retinopathy 
(80%). 
Indicators of Diabetic Control 
and Heart Disease Risk 
The intent of this investigation was to describe the relation-
ship of diabetic control and heart disease risk indicators of sub-
jects while using conventional insulin injections and while using 
the continuous subcutaneous insulin infusion pump. The subjects 
were followed for a six-month control period in which they continued 
to use conventional insulin injections for diabetic control. During 
the first and last weeks of the control period, Hb Alc, HDL, choles-
terol and triglyceride levels were obtained. The study period con-
sisted of the next consecutive three months when the subjects used 
insulin infusion pumps to obtain diabetic control. During the last 
week of the study period, Hb Alc, HDL, cholesterol and triglyceride 
levels were again measured. In reporting laboratory data, this 
study used normal values as defined by the hospital that conducted 
the tests. These values were: 
Hb Alc 
HDL 

























140 - 275 mg/dl 
50 - 200 mg/dl 
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Findings for each subject and for the group as a whole are in the 
following sections. 
Subject Number One 
Subject one was a 26-year-old male with a diabetic father and 
paternal grandfather. This subject was 10 years of age at the on-
set of diabetes, has now had diabetes for 15 years, and has taken 
insulin for the entire time. Prestudy insulin dose and schedule 
were 15 units of regular insulin and 15 units of intermediate-acting 
insulin in the morning in addition to 10 units of regular and 5 
units of intermediate-acting insulin in the evening. Existing dia-
betic complications included retinopathy, renal disease, and neuro-
pathy. All laboratory results for subject one are reported in Table 
6. Relationships between Hb Alc, HDL, cholesterol, and triglyceride 
levels are shown in Figure 2 for precontrol period, postcontrol per-
iod, and poststudy period results. 
The Hb Alc level increased from 10.9%to 14.6% hemoglobin (Hgb) 
during the control period, then decreased to 9% hemoglobin (Hgb) at 
the end of the study period, which was 1.9% Hgb below precontrol 
period level. Levels of HDL decreased from 42 to 36 mg/dl during 
the control period and remained at 36mg/dl during the study period. 
During the control period, the increase in Hb Alc and decrease in 
HDL created an inverse relationship. During the study period, the 
Hb Alc decreased while HDL remained at the same level. 
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Table 6 
Laboratory Results for Subject One 
Laboratory Test Con tro 1 Period Study Period 
Insulin Pump Use 
0 6 months 9 months 
HbAlc 10.9% Hgb 14.6% Hgb 9% Hgb 
HDL 42 mg/ dl 36 mg/dl 36 mg/dl 
Cholesterol 202 mg/dl 239 mg/dl 261 mg/dl 
Triglyceride 284 mg/dl 528 mg/dl 631 mg/dl 
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Cholesterol levels increased from 202 to 239 mg/dl during the 
control period, then continued to increase from 239 to 261 during 
the study period. All cholesterol levels remained within normal 
limits. During the control period, the relationship between HDL and 
cholesterol was inverse due to the decrease in HDL and increase in 
cholesterol levels. During the study period, HDL remained at the 
same level as cholesterol continued to increase. 
Triglyceride levels increased from 284 to 528 mg/dl during the 
control period, then continued to increase from 528 to 631 mg/dl 
during the study period. A triglyceride level of 631 mg/dl is three 
times the upper normal limit of 200 mg/dl. During the control period, 
an inverse relationship existed between HDL and triglyceride. During 
the study period, the HDL remained at the same level as the trigly-
ceride level increased. 
In summary, Hb Alc increased during the control period and then 
decreased during the study period. The HDL level decreased after 
the control period and remained at the same level. The Hb Alc and 
HDL had an inverse relationship during the control period. Levels 
of HDL were inversely related during the control period with both 
cholesterol and triglyceride, and as HDL remained at the same level, 
cholesterol and triglyceride continued to increase. 
Subject Number Two 
Subject two was a 26-year-old female with a diabetic paternal 
half-sister and a first cousin. This subject was 10 years old at the 
onset of diabetes, has now had diabetes for 15 years, and has taken 
48 
insulin for the entire time. Prestudy insulin dose included 10 units 
of regular and 12 units of intermediate acting insulin in the morn-
ing plus 6 units of regular and 8 units of intermediate-acting insu-
lin in the evening. Diabetic complications consisted of neuropathy 
and retinopathy. All laboratory results for subject two are given 
in Table 7. Relationships between HbAlc, HDL, cholesterol, and tri-
glyceride levels are depicted in Figure 3 for precontrol period, 
postcontrol period, and poststudy period results. 
The HbAlc levels decreased from 20.1 to 17% Hgb during the con-
trol period and continued to decrease from 17 to 12.1% Hgb during the 
study period. Levels of HDL increased from 28 to 56 ml/dl during the 
control period, then decreased from 56 to 52 mg/dl during the study 
period. During the control period, an inverse relationship between 
HbAlc and HDL was produced by the decrease in HbAlc and increase in 
HDL. During the study period, a direct relationship between HbAl: 
and HDL was produced by a decrease in both levels. 
Cholesterol levels decreased from 598 to 282 mg/dl during the 
control period which was 2.1 times less. Cholesterol then increased 
from 282 to 293 mg/dl during the study period. The relationship be-
tween HDL and cholesterol was inverse during the control period, as 
HDL increased and cholesterol decreased. During the study period, an 
inverse relationship also existed as HDL decreased and cholesterol 
increased. 
Triglyceride levels increased from 832 to 1250 mg/dl during 
the control period, then decreased from 1250 to 168 mg/dl during the 
study period which was 13% as much as the peak value. The relation-
ship between HDL and triglyceride was direct during the control 
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Table 7 
Laboratory Results for Subject Two 
Laboratory Test Control Period Study Period 
Insulin Pump Use 
0 6 Months 9 Months 
Hb A1c 20.1% Hgb 17.0% Hgb 12.1% Hgb 
HDL 28 mg/ d1 56 mg/dl 52 mg/dl 
Cholesterol 598 mg/dl 282 mg/d1 293 mg/d1 
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Figure 3, Subject Two. Relationship of Laboratory Test Results. U1 
o 
period as both levels increased. During the study period, the re-
lationship between HDL and triglyceride was also direct as both 
levels decreased. 
In summary, there was an inverse relationship between Hb Alc 
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and HDL levels during the control period and a direct relationship 
during the study period. Levels of HDL and cholesterol had an in-
verse relationship during both the control and study periods, while 
HDL and triglyceride levels had a direct relationship. 
Subject Number Three 
Subject three was a 30-year-old female with a diabetic sister. 
This subject was 16 years old at the onset of diabetes, has now had 
diabetes for 13 years, and has taken insulin for the entire time. 
Prestudy insulin dose consisted of 5 units of regular insulin in the 
morning and at noon, with 8 units of regular and 18 units of inter-
mediate-acting insulin in the evening. Diabetic complications in-
cluded retinopathy, cataracts, and neuropathy. All laboratory re-
sults are given in Table 8. The relationship between Hb Alc s HDL, 
cholesterol, and triglyceride levels is given in Figure 4 for pre-
control period, postcontrol period and poststudy period results. 
Levels of Hb Alc decreased from 11 to 9.1% Hgb during the 
control period, then increased from 9.1 to 10.3% Hgb during the 
study period. The HDL levels decreased from 54 to 50 mg/dl during 
the control period,then increased from 50 to 53 mg/dl during the 
study period. The relationship between Hb Alc and HDL was direct 
during both control and study periods. As Hb Alc decreased, HDL 
decreased, then when Hb Alc increased, HDL increased. 
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Table 8 
Laboratory Results for Subject Three 
Laboratory Test Control Period Study Period 
Insulin Pump Use 
0 6 Months 9 Months 
HbAlc 11% Hgb 9.1% Hgb 10.3% Hgb 
HDL 54 mg/dl 50 mg/ dl 53 mg/dl 
Cholesterol 186 mg/dl 175 mg/dl 198 mg/dl 
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Cholesterol levels decreased from 186 to 175 mg/dl during the 
control period, then increased from 175 to 198 mg/dl during the study 
period. The relationship between HDL and cholesterol was direct 
during both control and study periods. As HDL decreased, cholesterol 
decreased; and when HDL increased, cholesterol increased. 
Triglyceride levels increased from 135 to 162 mg/dl during the 
control period, then decreased from 162 to 84 during the study per-
iod. The relationship between HDL and triglyceride was inverse dur-
ing both the control and study period. As HDL decreased, triglyc~ 
eride increased, and then as HDL increased, triglyceride decreased. 
In summary, all levels remained within normal limits, except 
Hb Alc. There existed a direct relationship between Hb Alc and HDL 
throughout the control and study periods. The HDL relationship with 
cholesterol was direct, in contrast to an inverse relationship with 
triglyceride. 
Subject Number Four 
Subject four \lIas a 31-year-old fema 1 e who had no fami ly hi story 
of diabetes. This subject was 25 years old at the onset of diabetes, 
has now had diabetes for 5 years, and has taken insulin for the en-
tire time. Prestudy insulin dose was 20 units of intermediate-acting 
ins u 1 ina n d lOu nit s 0 flo n g -act i n gin s u 1 i n i n th e mo r n i n g, p 1 u s 1 0 
units of "intermediate-acting insul in and 10 units of long-acting insu-
1 in in the evening. Diabetic compl ications included retinopathy and 
neuropathy. All laboratory test results are reported in Table 9. 
Relationships between Hb Alc, HDL, cholesterol and triglyceride are 
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Table 9 
Laboratory Results for Subject Four 
Labora tory Test Control Period Study Period 
Infusion Pump Use 
0 6 Months 9 Months 
HbAlc 17.3% Hgb 19.2% Hgb 11.7% Hgb 
HDL 60 mg/dl 80 mg/dl 62 mg/dl 
Cholesterol 160 mg/dl 211 mg/dl 138 mg/dl 
Triglyceride 176 mg/dl 132 mg/d1 133 mg/dl 
shown in Figure 5 for precontrol period, postcontrol period, and 
poststudy period results. 
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Levels of HbAlc increased from 17.3to 19.2 Hbg during the con-
trol period, then decreased from 19.2 to 11.7 during the study per-
iod. The HDL levels increased from 60 to 80 mg/dl during the con-
trol period, then decreased from 80 to 62 mg/dl during the study 
period. Precontrol period and poststudy levels of HDL had a dif-
ference of 2 mg/dl. The relationship between HbAlc and HDL was 
direct during both the control and study periods. As HbAlc in-
creased, HDL increased; and as HbAlc decreased HDL decreased. 
Cholesterol levels increased from 160 to 211 mg/dl during 
the control period, then decreased from 211 to 138 mg/dl during the 
study period. The relationship between HDL and cholesterol was 
direct during both the control and study periods. As HDL increased, 
cholesterol increased; and as HDL decreased, cholesterol decreased. 
Triglyceride levels decreased from 176 to 132 mg/dl during the 
control period, then increased from 132 to 133 during the study peri-
od. The relationship between HDL and cholesterol was inverse during 
both the control and study periods. As HDL increased trig1yceride 
decreased; and as HDL decreased, triglyceride increased, although 
the increase in triglyceride during the study period was only 
1 mg/dl. Cholesterol and triglyceride levels were clinically with-
in normal limits with a difference no greater than 2. 
In summary, a direct relationship existed between HbAlc and 
HDL. The relationship between HDL and cholesterol was direct, in 
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Subject Number Five 
Subject five was a 26-year-old female with a diabetic brother 
and sister. This subject was 12 years old at the onset of diabetes 
and has had diabetes for l3i years, and has taken insul in for 13 
years. Prestudy insulin dose was 30 units of intermediate-acting 
insulin taken in the morning. Diabetic complications consisted of 
neuropathy and retinopathy. All laboratory test results are given 
in Table 10. Relationships between Hb Alc, HDL, cholesterol, and 
triglyceride levels are described in Figure 6 for precontrol period, 
postcontrol period, and poststudy period results. 
The Hb Alc levels decreased from 16.9 to 16.7% Hgb during the 
control period, and continued to decrease from 16.7% to 12.3% Hgb 
during the study period. Levels of HDL decreased from 91 to 69 mg/ 
dl during the control period, and continued to decrease from 69 to 
66 mg/dl during the study period. The relationship between Hb Ale 
and HDL was direct during both the control and study periods. As 
Hb Alc decreased, HDL decreased. 
Cholesterol levels increased from 166 to 179 mg/dl during the 
control period, then decreased from 179 to 152 mg/dl during the study 
period. All cholesterol levels were within normal limits. The 
relationship between HDL and cholesterol was inverse during the con-
trol period which was produced by a decrease in HDL and increase 
"in cholesterol. During the study period, a direct relationship exis-
ted between HDL and cholesterol which was produced by a decrease in 
both HDL and cholesterol. 
Triglyceride levels decreased from 75 to 72 mg/dl during the 
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Table 10 
Laboratory Results for Subject Five 
Laboratory Test Contro 1 Period Study Period 
Infusion Pump Use 
0 6 Months 9 Months 
Hb Alc 16.9% Hgb 16.7% Hgb 12.3 % Hgb 
HDL 91 mg/d1 69 mg/dl 66 mg/d1 
Cholesterol 166 mg/dl 179 mg/ dl 152 mg/dl 
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control period and continued to decrease from 72 to 37 mg/dl during 
the study period. The relationship between HDL and triglyceride was 
direct during both control and study periods. As HDL levels de-
creased, triglyceride levels decreased. 
In summary, there was a direct relationship between Hb Alc and 
HDL during the control and study periods, although there was an in-
significant change in Hb Alc during the control period, and an in-
significant change in HDL during the study period. The relationship 
between HDL and cholesterol was inverse during the control period 
and was direct during the study period. The relationship between 
HDL and triglyceride was direct for both control and study periods. 
The Group As A Whole 
The range and mean values of Hb Alc, HDL, cholesterol, and 
triglyceride for the precontrol period, postcontrol period, a~d post-
study period are given in Table 11. The relationships between Hb 
Alc, HDL, cholesterol and triglyceride mean levels are depicted in 
Figure 7. 
The mean Hb A1c increased from 15.24 to 15.32% Hgb during the 
control period, then decreased from 15.32 to 11.08% Hgb during the 
study period. Levels of mean HDL increased from 55 to 58.2 mg/dl 
during the control period, then decreased from 58.2 to 53.8 mg/d1 
during the study period. All mean HDL levels were within normal 
range. The relationship between mean Hb Alc and HDL was direct for 
both the control and study periods. As Hb Alc increased, HDL in-







Laboratory Results for the Group as a Whole 
Control Period Study Peri od 
Insulin Pump Use 
o months 6 months 9 months 
Range ~1ean Range Mean Range Mean 
10.9-20.1 15.24% Hgb 9.1-19.2 15.32% Hgb 9-12.3% Hgb 11.08% Hgb 
% Hgb % Hgb 
28-91 mg/ d1 55 mg/ d1 36-80 mg/d1 58.2 mg/dl 36-66 mg/d1 53.8 mg/dl 
160-598 mg/d1 262.4 mg/d1 175-282 mg/d1 217.2 mg/d1 138-293 mg/d1 208.4 mg/d1 
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Mean cholesterol levels decreased from 262.4 to 217.2 mg/dl 
during the control period, and continued to decrease from 217.2 to 
208.4 mg/dl during the study period. The relationship between mean 
HDL and cholesterol was inverse during the control period, then direct 
during the study period. As HDL increased, cholesterol decreased, 
and as HDL decreased, cholesterol decreased. 
Mean triglyceride levels increased from 300.4 to 428.8 mg/dl 
during the control period, then decreased from 428.8 to 210.6 mg/dl 
during the study period. The relationship between mean HDL and 
triglyceride was direct. As HDL increased, triglyceride increased; 
as HDL decreased, triglyceride decreased. 
In summary, mean Hb Alc and HDL had a direct relationship during 
the control and study periods. The mean HDL had an inverse rela-
tionship with cholesterol during the control period then a direct 
relationship during the study period. Whereas mean HDL and triglyc-
eride had a direct relationship during both the control and study 
periods. 
This chapter has described the five diabetic subjects as 
individuals and as a group. Laboratory results and relationships 
of Hb Alc, HDL, cholesterol, and triglyceride have been given in 
tables and figures for precontrol, postcontrol, and poststudy pe-
riods. 
CHAPTER IV 
DISCUSSION, SUMMARY, AND 
RECOMMENDATIONS 
Discussion 
The leading cause of death in the industrialized world is CAHD. 
In the general population, the morbidity of CAHD is significantly 
greater for diabetic persons in comparison to nondiabetic persons. 
Current data give evidence that the atherosclerotic process in dia-
betic persons does not differ from nondiabetic persons. However, the 
atherosclerotic process proceeds more rapidly and extensively in 
diabetic persons. Researchers believe that the inherent character-
istics of the diabetic state contribute to the acceleration and ex-
tensiveness of atherosclerosis observed in diabetic persons. Dia-
betic control -- normoglycemia and normal insulinemia -- can de~ 
crease these inherent diabetic characteristics which are directly 
related to atherosclerosis. Therefore, diabetic control may de-
crease and possibly slow the progression of atherosclerosis in dia-
betic persons. Better diabetic control can be provided by the con-
tinuous subcutaneous insulin infusion pump than by conventional in-
sulin injections, according to the literature. 
Indicators for long-term diabetic control and heart disease 
risk are Hb Alc and HDL respectively. These indicators have been 
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employed to determine the relationship of diabetic control and heart 
disease risk while the diabetic subject was using conventional insu-
lin injections and while the subject was using the continuous sub-
cutaneous insulin infusion pump. The purpose of this study was to 
describe the effect of diabetic control on heart disease risk. 
Group Biographical Data 
The mean age for the five subjects was 27.8 years with a mean 
of 12.4 years duration of diabetes. An identical average age group 
of nondiabetic persons would not be expected to have the chronic 
health problems seen in this young age sample. One hundred percent 
of this sample of diabetic subjects have developed one or more 
diabetic complications within the last 5 to 15 years. These dia-
betic complications -- neuropathy, retinopathy, and renal disease 
are directly associated with inadequate or poor diabetic control. 
At the end of this investigation, some changes in renal func-
tion tests were documented, while changes in retinopathy and neurop-
athy will be documented later. For the two subjects with renal 
disease (subjects one and four), the disease increased during the 
control period but showed no change (subject one) or slight improve-
ment (subject four) during the study period. This can be interpreted 
that as diabetic control improved, further decrease in renal func-
tion was halted. 
Although no signs or symptoms of heart disease were found in 
this group of subjects, their medical history suggests heart disease 
is likely to develop in the future. 
Indicators for Diabetic Control and 
Heart Disease Risk 
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Discussion of the relationship of indicators for diabetic con-
trol and heart disease risk will be given for each subject and then 
for the group as a whole. The research questions will be answered 
and discussed with conclusions. 
For interpretation purposes, the following changes in Hb Alc, 
HDL, cholesterol, and triglyceride are considered insignificant: 
Hb Alc ~ 2% Hgb 
HDL _~ 5 mg/dl 
Cholesterol ~ 9 mg/dl 
Triglyceride ~ 9 mg/dl 
Subject Number One. The Hb Alc increased during the control 
period but then decreased during the study period. This suggests 
that diabetic control was inadequate while the subject was using 
the conventional insulin injections. The use of the insulin pump 
provided improved control as demonstrated by the Hb Alc which de-
creased to clinically normal range (difference of 0.5% Hgb). This 
corresponds with the literature. 
The HDL levels decreased during the control period and remained 
at the same level during the study period. The decrease in HDL and 
increase in Hb Alc, or inverse relationship, during the control per-
iod is consistent with the literature. The decrease in Hb Alc with 
the same level of HDL during the study period could be the result of 
diabetic control not being adequate enough for HDL levels to change. 
With continued use of the insulin pump and improved control, the 
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Hb Alc should continue to decrease and HDL should begin to increase. 
The inverse relationship of HDL to cholesterol and triglyceride 
correlates with the literature. The increase in triglyceride with 
an increase of Hb Alc during the control period is also consistent 
with the literature, suggesting that poor diabetic control, with 
inadequate amounts of insulin, contributes to hypertriglyceridemia. 
The continued increase of triglyceride in the study period indicates 
that although diabetic control improved with the insulin pump, the 
control was not as good as it could have been. 
In summary, this subject1s diabetic control was better with the 
insulin pump than with insulin injections, showing clinically sig-
nificant changes in Hb Alc during the control and study periods 
(3.7% Hgb increase and 5.6% Hgb decrease). An inverse relationship 
existed between Hb Alc and HDL during the control period, but as 
Hb Alc decreased during the study period, HDL remained the same. 
With these changes in HDL, both cholesterol and triglyceride levels 
increased, further suggesting diabetic control could have been 
better. 
Subject Number Two. The Hb Alc decreased significantly through-
out the control (3. 1 % Hgb) and study (4. 9% Hgb) peri ods, a 1 though 
never reaching normal limits. This indicates diabetic control im-
proved during both the control and study periods, with the best dia-
betic control obtained while the infusion pump was used. There was 
an inverse relationship between Hb Alc and HDL during the control 
period. The direct relationship in the study period can be clini-
cally interpreted as an inverse relationship since the decrease 
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in Hb Alc level was significant (4.9% Hgb), whereas the decrease in 
HDL level was not clinically significant (4 mg/dl). These results 
are compatible with the literature. 
An inverse relationship existed between HDL and cholesterol; 
which is congruent with literature reports. The significant increase 
in HDL (28 mg/dl) with a significant decrease in cholesterol (316 
mg/dl) gives evidence to the significant improvement in diabetic con-
trol. A direct relationship existed between HDL and triglyceride 
which is not uniform with the literature. The high levels of tri-
glyceride during the control period are a result of poor diabetic 
control as indicated by high Hb Alc levels. The significant decrease 
in triglyceride (1082 mg/dl) in the study period was a result of 
improved diabetic control. The relationship between HDL and tri-
glyceride was a consequence of poor diabetic control, thus changing 
the HDL correlation. 
In summary, this subject's diabetic control significantly im-
proved during the control and study periods with the best control 
achieved with the insulin pump. A significant increase of HDL oc-
curred in the control period with an insignificant decrease in the 
study period. There was an inverse relationship between Hb Alc and 
HDL during the control period and an insignificant direct relation-
ship during the study period. 
The relationship of HDL to cholesterol was inverse during the 
control and study periods with insignificant changes of both indi-
cators in the study period. The relationship between HDL and tri-
glyceride was direct, which was primarily due to inadequate 
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control during the control period as reflected by high Hb Alc levels. 
The significant decrease in triglyceride with insignificant decrease 
in HDL is meaningful and suggests an inverse clinical relationship. 
Subject Number Three. The Hb Alc decreased during the control 
period (1.9% Hgb) but then increased during the study period (1.2% 
Hgb), although these changes are not clinically significant. This 
indicates that diabetic control was similar whether the subject was 
using insulin injections or the infusion pump. However, diabetic 
control could be more adequate with the use of the insulin pump. 
With continued adjustment in basal and bolus insulin amounts of the 
infusion pump, improved diabetic control should result when the prop-
er insulin dosage schedule is achieved. 
The HDL levels remained within normal limits with a decrease 
during the control period (4 mg/dl) and an increase during the 
study period (3 mg/dl). These changes are not clinically signifi-
cant. A direct relationship existed between Hb Alc and HDL. This 
is not a significant finding, since changes in both Hb Ale and HDL 
are not clinically significant. 
Cholesterol decreased during the control period but then in-
creased during the study period with all changes being within nor-
mal limits. The direct relationship of cholesterol with HDL does 
not correspond with the literature. Therefore, the changes in cho-
lesterol could be a result of dietary or other interference with 
the test results. 
An inverse relationship existed between HDL and triglyceride; 
this is uniform with the literature. All triglyceride levels were 
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within normal limits. The significant decrease during the study 
period (78 mg/dl) is also an indicator of improved diabetic control. 
In summary, diabetic control did not improve significantly 
while the subject was using the insulin pump, resulting in insignif-
icant changes in Hb Alc and HOL. Cholesterol and triglyceride 
remained within normal limits, although significant changes occurred 
during the study period. 
Subject Number Four. There was an increase in Hb Alc during 
the control period (1.9% Hgb) with a significant decrease during the 
study period (7.5% Hgb). This indicates better diabetic control 
was achieved with the infusion pump. Levels of HOL increased during 
the study period but then decreased to near precontrol period level, 
making a direct relationship with Hb Alc. This relationship does 
not correlate with the literature. However, as diabetic control 
improved, HDL levels remained within upper normal limits. 
A direct relationship existed between HDL and cholesterol; this 
does not correlate with the literature. However, cholesterol re-
mained within normal limits. Thus other factors such as dietary 
interference are contributing to the cholesterol level changes. The 
inverse relationship of HOL to triglyceride does correlate with the 
literature, although the change in triglyceride level is insignifi-
cant during the study period (1 mg/dl). 
In summary, the relationships between Hb Alc and HDL, and HDL 
and cholesterol do not correlate with the literature. However, im-
proved diabetic control is indicated by the significant decrease in 
Hb Alc during the study period while the infusion pump was being 
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used, and perhaps with more time diabetic control will be sufficient 
for HOl to increase and cholesterol to decrease. The relationship 
between HOl and triglyceride was inverse. 
Subject Number Five. The insignificant decrease in Hb Alc lev-
els (0.2% Hgb) during the control period indicated that diabetic 
control remained the same while using insulin injections. The sig-
nificant decrease in Hb Alc (4.4% Hgb) during the study period indi-
cated improved diabetic control while using the insulin infusion 
pump. The direct relationship of Hb Alc to HOl is not consistent 
with the literature. However, the insignificant decrease in HDl 
(3 mg/dl) during the study period with a significant decrease in 
Hb Alc (4.4% Hgb) suggested an inverse relationship may be forth-
coming. 
The relationship between HOl and cholesterol was inverse during 
the control period and direct during the study period. The insignif-
icant decrease in HOl (3 mg/dl) during the study period with a sig-
nificant decrease in cholesterol (27 mg/dl) suggest an inverse rela-
tionship. With this interpretation, the relationship between HOl 
and cholesterol was consistent with the literature. 
The HOl and triglyceride relationship was direct. The insig-
nificant decrease in triglyceride (3 mg/dl) with a significant de-
crease in HDl (22 mg/dl) during the control period, plus the signif-
icant decrease in the triglyceride (35 mg/dl) in the study period 
with an insignificant decrease in HOl (3 mg/dl) suggest an inverse 
relationship which was consistent with the literature. In addition, 
triglyceride and Hb Alc relationship was direct which was also 
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consistent with the literature and indicative of inadequate control. 
In summary, improved diabetic control did occur when the in-
sulin pump was used. Absolute relationsh-ips between HbAlc and HDL, 
HDL and cholesterol, and HDL and triglyceride levels were not consis-
tent with the literature. 
The Group as a Whole. An insignificant increase occurred in 
the group mean Hb Alc (0.08% Hgb) during the control period with a 
significant decrease (4.24% Hgb) during the study period. This in-
dicated better diabetic control was achieved for the subjects when 
the infusion pump was used, which conformed to the literature. Levels 
of mean HDL increased (3.2 mg/dl) during the control period then 
decreased (4.4 mg/dl) during the study period which created a direct 
relationship between mean HDL and Hb Alc. This relationship does 
not correspond with the literature. However, the changes in HDL 
levels were insignificant when compared to Hb Alc levels during the 
study period. 
The relationship between mean HDL and cholesterol was inverse 
during the control period and direct during the study period. 
Changes in HDL (4.4 mg/dl) and cholesterol (8.8 mg/dl) during the 
study period were insignificant clinically. A direct relationship 
existed between mean HDL and triglyceride during both the control 
and study periods. The significant changes in triglyceride levels 
(127.6 and 217.4 mg/dl) can be attributed to subject two whose tri-
glyceride levels were 832 and 1250 mg/dl during the control period, 
which increased the mean value. 
The direct relationship between mean Hb Alc and triglyceride 
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suggested that triglyceride values were also a function of Hb Alc 
levels, which was indicated by the significant drop in both Hb Alc 
and triglyceride during the study period. This correlated with the 
literature. 
In summary, the group's diabetic control improved significantly 
while using the insulin infusion pump. The direct relationship be-
tween mean Hb Alc and HDL did not correspond with the literature. 
The relationship between mean HDL and cholesterol was inverse during 
the control period and was direct during the study period. A direct 
relationship existed between mean HDL and triglyceride. 
Conclu ion 
The Hb Alc levels indicated that diabetic control improved 
during the control period, in three subjects (0.2 - 3.1% Hgb increase), 
which was likely to be an effect of participation in a diabetic 
control study. Diabetic control deteriorated for two subjects (1.9 
- 3.7% Hgb decrease) during the control period which indicated in-
sulin injections did not adequately control their diabetes. The 
mean Hb Alc levels indicated a 0.08% Hgb increase in Hb Alc which 
was an insignificant change in diabetic control during the control 
period. Therefore, Hb Alc levels did not change significantly dur-
ing the six month control period for this group of subjects, al-
though significant changes did occur in subjects one and two. 
During the control period, HDL levels decreased in three sub-
jects (4 - 22 mg/dl decrease) and increased in two subjects (20 -
28 mg/dl). An increase in HDL was expected in the three subjects 
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whose Hb Alc level decreased and diabetic control improved. A de-
crease in HDL was expected in the two subjects whose Hb Alc level 
increased and diabetic control deteriorated. The mean HDL level 
increased (3.2 mg/dl) during the control period. Therefore, HDL 
levels changed significantly during the six month control period 
in subjects two, four and five, but did not change significantly 
for the group as a whole. 
Subjects one and two had an inverse relationship between Hb 
Alc and HDL during the control period. The direct relationship 
between Hb Alc and HDL in the other three subjects was not expected 
and did not conform with the literature. The mean Hb Alc and HDL 
levels for the group had a direct relationship with an insignificant 
increase in Hb Alc and a significant increase in HDL. Therefore, 
the relationship between Hb Alc and HDL was inverse for two sub-
jects, although a direct relationship existed between Hb Alc and 
HDL for the group during the control period. 
During the study period four subjects had a decrease in Hb 
Alc (4.4 to 7.5 % Hgb) and one subject had an increase in Hb Alc 
(1.2 % Hgb). The increase in Hb Alc (1.2% Hgb) in subject three 
was insignificant while using the insulin pump. Diabetic control 
improved in four subjects when using the insulin pump. The mean 
values for Hb Alc decreased during the study period which indi-
cated diabetic control improved for the group when using the insu-
lin pump. Therefore, Hb Alc levels decreased from control period 
levels after the insulin pump had been used for three months. 
Although diabetic control improved for subjects during the 
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control and study periods, Hb Alc levels never decreased to normal 
values. Diabetic control could have been appreciably better with 
more aggressive management. This suggests that diabetic control 
can continue to improve with adjustments in the infusion pump basal 
and bolus rates. 
During the study period HDL levels decreased in subject two, 
four, and five (3 - 18 mg/dl), remained the same for subject one, 
and increased in subject three (3 mg/dl). The increase of HDL in 
subject three was expected with improved diabetic control. The 
subjects whose HDL remained the same or whose HDL decreased did not 
conform to the expectation from the literature. Other influences 
on HDL levels are the risk factors for heart disease which this 
study did not control, such as diet and smoking. The mean HDL 
levels decreased (4.4 mg/dl) during the study period, which is not 
significant. Therefore, the HDL level did not increase from con-
trol levels after the insulin pump had been used for three months. 
Subjects two, three, four, and five had a direct relationship 
between Hb Alc and HDL during the study period. The Hb Alc de-
creased as HDL remained at the same level in subject one. 
values of Hb Alc and HDL also had a direct relationship. 
The mean 
The lack 
of inverse relationship between Hb Alc and HDL is unexpected and 
does not correlate with the literature. Explanations for this 
are: a) Hb Alc did not decrease sufficiently to cause an inverse 
relationship; or b) other factors changed the Hb Alc and HDL values. 
Therefore, HbAlc and HDL levels were not inversely related after 
three months of insulin pump use. 
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An inverse relationship between HDL and cholesterol existed 
in subjects one, two and five during the control period, and exis-
ted in subject two during the study period. Although the number of 
subjects with this inverse relationship was lower than expected, 
subjects one, three, four, and five had all cholesterol levels with-
in normal limits. The relationship of the mean values of HDL and 
cholesterol were inverse during the control period, then direct 
during the study period. This suggested that other uncontrolled 
variables must be influencing the HDL and cholesterol relationship. 
These variables may be heart disease risk factors such as diet and 
smoking. However, with the same or improved diabetic control, cho-
lesterol levels decreased during both control and study periods, 
which suggested a relationship between Hb Alc and cholesterol. 
Therefore, the relationship between HDL and cholesterol was inverse 
only in the control period. 
An inverse relationship between HDL and triglyceride existed 
in subjects one, three, and four during the control period, and 
existed in subject three during the study period. Three subjects 
had triglyceride levels within clinically normal range. The rela-
tionship between mean HDL and cholesterol was direct during both the 
control and study periods. This was not consistent with the liter-
ature. However, a direct relationship bewteen Hb Alc and triglycer-
ide is consistent with the literature, indicating poor diabetic con-
trol or increased Hb Alc level is related to hypertriglyceridemia. 
Therefore, with increased Hb Alc levels, an inverse relationship 
could not exist between HDL and triglyceride. 
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Summary and Implications 
The data in this study of diabetic subjects gives evidence that 
diabetic control can be significantly improved when using the contin-
uous subcutaneous insulin infusion pump. Levels of Hb Alc did not 
change significantly during the six month control period when insu-
lin injections were used. The Hb Alc decreased below control peri-
od levels after the infusion pump had been used for three months. 
However, the relationship between diabetic control (Hb Alc) and 
heart disease risk (HDL) could not be determined. 
Levels of HDL did not change significantly during the control 
or study periods in this group of diabetic subjects. The relation-
ship between Hb Alc and HDL was direct for both the control and 
study period. Relationships between HDL and cholesterol were in-
verse during the control period, then direct during the study peri-
ods. Relationships between HDL and triglyceride were direct for 
both the control and study periods. These results do not conform 
to the literature and suggest other variables are influencing these 
relationships. These variables are likely to be other heart disease 
risk factors. In addition, poor diabetic control produces increased 
triglyceride levels. 
When determining the effect of diabetic control on heart dis-
ease risk, other variables in addition to diabetic control (Hb Alc) 
and heart disease risk (HDL) should be measured and controlled. 
These variables should include risk factors for heart disease which 
are age, family history, elevated lipid levels, diet, hypertension, 
smoking, lifestyle, and psychosocial tension. 
79 
Diabetic persons should be educated about the availability and 
use of the insulin infusion pump. These persons should be aware 
that diabetic control can improve significantly as indicated by this 
and other studies. When diabetic control is improved, a decrease 
in the rate and amount of diabetic complications should be seen. 
This is currently being studied in the larger investigation by four 
physicians. 
Limitations and Recommendations 
It was assumed in this study that the infusion pumps would func-
tion properly; the subjects could operate the infusion pumps correct-
ly; and subjects would continue their normal lifestyle. The major 
limitations and uncontrolled variables in this study included: 
1. No control over antecedent events which may have affected 
diabetic control at the beginning of the study. 
2. No control over the knowledge and comprehension of the 
subjects. 
3. No control over the accuracy, dependability and, compulsion 
of the diabetic subjects in recording events, measuring blood glu-
cose levels, and managing the insulin infusion pump. 
The relationship between diabetic control and heart disease 
risk in diabetic persons is a significant and important problem 
which requires further research. Replication of this study with a 
larger sample, longer control and study periods, and control of 
heart disease risk factors should produce more significant data re-
sults. As physicians gain more experience in managing diabetic 
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persons using the infusion pump, the average time to obtain good 
diabetic control and normal Hb Alc levels should decrease. Another 
area that should be studied is the compliance of diabetic persons 
using the infusion pump. 
In conclusion, diabetic control improved significantly in five 
diabetic subjects while using the insulin infusion pump. The signif-
icance in this finding lies in the direct relationship between dia-
betic control and diabetic complications. The relationships between 
diabetic control and heart disease risk factors -- HDL, cholesterol, 
and triglyceride -- were not conclusive. Relationships between HbAlc, 
HDL, cholesterol, and triglyceride did not conform to the litera-
ture or expectations. This indicates that other variables were 
changing the heart disease risk indicators, which in turn changed 
the relationship between diabetic control and heart disease risk. 
This study should be replicated with control over these variables 
to establish a significant relationship between diabetic control and 
heart disease risk. 
APPENDIX 






Do any of your relatives have diabetes? Yes No 
Relationship Age Age Onset Insulin Used? 
Relative with OM: -------------------------------------------
Personal History: 
Age at onset of your diabetes (yrs.) 
Duration of diabetes (yrs.) 
Insul in-dependent? ---'yes __ no 
Duration of insulin use (yrs.) 
Maximum insulin dose 
Number of injection .~----------------------
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